Klox Technologies Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 33
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $5.47M
Latest Deal Amount
  • Investors
  • 1

Klox Technologies General Information

Description

Developer of a regenerative medicine intended to revive skin at a cellular level. The company's medicine targets specific skin and soft tissue conditions by controlling the benefits of fluorescence generated energy to penetrate and manage the skin from within, enabling clinicians to focus on indications in the areas of dermatology, wound care, and oral health to improve patient outcomes without compromise.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 275 Boulevard Armand-Frappier
  • Laval, Quebec H7V 4A7
  • Canada
+1 (866) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Klox Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC $5.47M 00.000 Completed Generating Revenue
1. IPO 11-Feb-2015 000.00 00000 Cancelled Generating Revenue
To view Klox Technologies’s complete valuation and funding history, request access »

Klox Technologies Patents

Klox Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210228720-A1 Absorbent biophotonic fiber system Pending 05-Jun-2018 000000000000
CA-3102437-A1 Absorbent biophotonic fiber system Pending 05-Jun-2018 000000000000
JP-2021525778-A Absorbable biophotonic fiber system Pending 05-Jun-2018 000000000000
EP-3801653-A1 Absorbent biophotonic fiber system Pending 05-Jun-2018 000000000000
AU-2019280457-A1 Absorbent biophotonic fiber system Pending 05-Jun-2018 A61F13/00008

Klox Technologies Executive Team (4)

Name Title Board Seat Contact Info
Francesco Bellini Ph.D Co-Chief Executive Officer & Chairman
Carlo Bellini President and Board Member
Lise Hébert Ph.D Co-Chief Executive Officer, President, Executive Vice President, Innovation, Government & NA Clinical Affairs & Board Member
Joseph D'Abramo Senior Vice President of Finance, HR and Supply Chain
To view Klox Technologies’s complete executive team members history, request access »

Klox Technologies Board Members (12)

Name Representing Role Since
Carlo Bellini Klox Technologies President and Board Member 000 0000
Cesilde Spalvieri Klox Technologies Board Member 000 0000
Charles Herington Self Board Member 000 0000
Domenic Serafino Self Board Member 000 0000
Francesco Bellini Ph.D Klox Technologies Co-Chief Executive Officer & Chairman 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Klox Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Klox Technologies Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Scientia Ventures Venture Capital Minority 000 0000 000000 0
To view Klox Technologies’s complete investors history, request access »

Klox Technologies Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 0000000000 04-Oct-2019 0000000000 Other Healthcare Services
To view Klox Technologies’s complete acquisitions history, request access »

Klox Technologies Subsidiaries (1)

Company Name Industry Location Founded
00 00000000000 Other Healthcare Services Dublin, Ireland 0000
To view Klox Technologies’s complete subsidiaries history, request access »